Emily Ruiz

Sep 22, 2023 | dermatologytimes.com | Gina Battaglia |Brent Moody |Sarah T Arron |Justine V. Cohen |Emily Ruiz |Todd E. Schlesinger

Continued from part 3#1: Man With Large BCC on the Left TempleFor Schlesinger’s patient with a large BCC lesion on his left temple, the panelists said they would likely choose Mohs surgery. Assessing the risk of disease progression is important because the lesion’s raised appearance suggests a high likelihood of deep invasion, microscopic positive margins after surgery, and lymph node involvement, said Schlesinger.

Sep 20, 2023 | dermatologytimes.com | Gina Battaglia |Brent Moody |Sarah T Arron |Justine V. Cohen |Emily Ruiz |Todd E. Schlesinger

Continued from part 2Ruiz noted that the type of skin cancer is the major factor in her decision to pursue nonsurgical treatment, and she has found that Mohs surgery is usually the easiest treatment for patients with BCC. However, the multidisciplinary team, the patient, and the patient’s family should all be involved in the decision-making process.

Sep 15, 2023 | dermatologytimes.com | Gina Battaglia |Brent Moody |Sarah T Arron |Justine V. Cohen |Emily Ruiz |Todd E. Schlesinger

Continued from part 1Although there is no standard definition for advanced BCC, Arron defines it informally as BCC that is not amenable to curative surgical resection or radiation therapy, or for which these treatments would cause substantial morbidity and decreased quality of life. However, determination of resectability is heavily reliant on the surgeon and the patient’s ability to access different surgical options, she added. This presents an opportunity for multidisciplinary care.

Sep 13, 2023 | dermatologytimes.com | Gina Battaglia |Brent Moody |Sarah T Arron |Justine V. Cohen |Emily Ruiz |Todd E. Schlesinger

“A lot of our colleagues in practice still have a lot of gaps in their understanding of systemic therapies for basal cell carcinoma [BCC],” said Brent Moody, MD, to kick off the discussion surrounding the improvement of BCC management.

Jun 1, 2023 | dermatologytimes.com | Emily Ruiz |Todd E. Schlesinger

2 Minute DrillAround the PracticeBetween The LinesCase Based Peer PerspectiveDermViewEditorial Board NewsExpert InterviewsExpert PerspectivesFrontline ForumInside the ClinicMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and ReferViewpointsWebinars